AstraZeneca

Open: 68.31 Close: 68.38 Change: 0.07

You don't have time to read all about AstraZeneca. An AI summarizes all the information for you.

Are looking for the most relevant information about AstraZeneca? Investor spend a lot of time searching for information to make investment decisions in AstraZeneca. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, Chinese, Gracell, cell, therapy, RSV, company, and the most common words in the summary are: astrazeneca, gracell, news, therapy, china, company, cell, . One of the sentences in the summary was: Chinese National Medical Products Administration has granted approval for AstraZeneca.. Other searches related to …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

China approves shot co-developed by Astrazeneca and Sanofi to ward off RSV infection. Chinese National Medical Products Administration has granted approval for AstraZeneca.

Today's News

Chinese National Medical Products Administration has granted approval for AstraZeneca and Sanofi s monoclonal antibody, Beyfortus (nirsevimab), to prevent respiratory syncytial virus (RSV) in neonates and infants. BeyFortus received approval in the European Union in October 2022 for usage in newborns and infants during their first RSV season in. AstraZeneca to buy Gracell Biotechnologies for up to $1.2 billion. GlobalData predicts that the top trend in the pharma industry in 2024 will be cell and gene therapy. AstraZeneca (AZN) agreed to purchase the biopharma company for $1.1 billion to expand its reach into cutting-edge vaccine and immune therapy business. Shares of Icosavax (ICVX) skyrocketed over 48% in early trading Tuesday. Miracle Mile Advisors LLC cut its position in AstraZeneca PLC (NASDAQ:AZN) by 1.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. New options become available today for the February 23rd expiration. AstraZeneca to buy Chinas Gracell Biotechnologies in $1.2 billion deal. Icosavax Sued over astrazeneca Takeover Conflicts, Projections, lawsuit says. Allorion Therapeutics has entered into an exclusive option and global license agreement with AstraZeneca. Agreement includes upfront and near-term payments of up to $40 million. Agreement is aimed at treating advanced EGFR-mutant non-small cell lung cancer. AstraZeneca picks up friend for tagrisso in $40M upfront deal for Tagrisso. China approves shot co-developed by Astrazeneca and Sanofi to ward off RSV infection. Astrazeneca (azn) stock falls amid market uptick: what investors need to know. Astrazenecas vaccine is deemed safe by europe. will people want it? AstraZeneca will acquire Chinese cell therapy maker Gracell for up to $1.2 billion, representing an 86% premium to the companies pre-announcement share price. The deal represents a potential new exit path for investors in early-stage Chinese drug companies. AstraZeneca will acquire Chinese cell therapy maker Gracell for up to $1.2 billion. The move, announced on December 26, 2023, did not affect AstraZecas financial guidance for last year.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

This document will help you to evaluate AstraZeneca without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, Chinese, Gracell, cell, therapy, RSV, company, and the most common words in the summary are: astrazeneca, gracell, news, therapy, china, company, cell, . One of the sentences in the summary was: Chinese National Medical Products Administration has granted approval for AstraZeneca.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #gracell #news #therapy #china #company #cell.